Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.

Hicks CW, Li Y, Okugawa S, Solomon SB, Moayeri M, Leppla SH, Mohanty A, Subramanian GM, Mignone TS, Fitz Y, Cui X, Eichacker PQ.

Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H1108-18. doi: 10.1152/ajpheart.01128.2010. Epub 2011 Jan 7.

2.

Injection anthrax causing compartment syndrome and necrotising fasciitis.

Parcell BJ, Wilmshurst AD, France AJ, Motta L, Brooks T, Olver WJ.

J Clin Pathol. 2011 Jan;64(1):95-6. doi: 10.1136/jcp.2010.082586. Epub 2010 Nov 20. No abstract available.

PMID:
21097792
3.

Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines.

Sweeney DA, Cui X, Solomon SB, Vitberg DA, Migone TS, Scher D, Danner RL, Natanson C, Subramanian GM, Eichacker PQ.

J Infect Dis. 2010 Dec 15;202(12):1885-96. doi: 10.1086/657408. Epub 2010 Nov 10.

4.

Anthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism.

Kandadi MR, Hua Y, Ma H, Li Q, Kuo SR, Frankel AE, Ren J.

PLoS One. 2010 Oct 13;5(10):e13335. doi: 10.1371/journal.pone.0013335.

5.

A review of cutaneous anthrax and its outcome.

Doganay M, Metan G, Alp E.

J Infect Public Health. 2010;3(3):98-105. doi: 10.1016/j.jiph.2010.07.004. Epub 2010 Aug 24. Review.

6.

Constitutive MEK1 activation rescues anthrax lethal toxin-induced vascular effects in vivo.

Bolcome RE 3rd, Chan J.

Infect Immun. 2010 Dec;78(12):5043-53. doi: 10.1128/IAI.00604-10. Epub 2010 Sep 20.

7.

Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.

Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ.

N Engl J Med. 2010 Aug 19;363(8):766-77. doi: 10.1056/NEJMcpc1003887. No abstract available.

PMID:
20818879
8.

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Wright JG, Quinn CP, Shadomy S, Messonnier N; Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2010 Jul 23;59(RR-6):1-30.

9.

Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Jul 23;59(28):872-7.

10.

The surgical management of injectional anthrax.

Jallali N, Hettiaratchy S, Gordon AC, Jain A.

J Plast Reconstr Aesthet Surg. 2011 Feb;64(2):276-7. doi: 10.1016/j.bjps.2010.06.003. Epub 2010 Jul 7. No abstract available.

PMID:
20615773
11.

Anthrax infection in drug users.

Booth MG, Hood J, Brooks TJ, Hart A; Health Protection Scotland Anthrax Clinical Network..

Lancet. 2010 Apr 17;375(9723):1345-6. doi: 10.1016/S0140-6736(10)60573-9. No abstract available.

PMID:
20399978
12.

Transcriptome dysregulation by anthrax lethal toxin plays a key role in induction of human endothelial cell cytotoxicity.

Rolando M, Stefani C, Flatau G, Auberger P, Mettouchi A, Mhlanga M, Rapp U, Galmiche A, Lemichez E.

Cell Microbiol. 2010 Jul;12(7):891-905. doi: 10.1111/j.1462-5822.2010.01438.x. Epub 2010 May 20.

PMID:
20088950
13.

Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009.

Radun D, Bernard H, Altmann M, Schöneberg I, Bochat V, van Treeck U, Rippe RM, Grunow R, Elschner M, Biederbick W, Krause G.

Euro Surveill. 2010 Jan 14;15(2). pii: 19464.

14.

The role of Bacillus anthracis germinant receptors in germination and virulence.

Carr KA, Lybarger SR, Anderson EC, Janes BK, Hanna PC.

Mol Microbiol. 2010 Jan;75(2):365-75. doi: 10.1111/j.1365-2958.2009.06972.x. Epub 2009 Nov 25.

15.

Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model.

Cui X, Su J, Li Y, Shiloach J, Solomon S, Kaufman JB, Mani H, Fitz Y, Weng J, Altaweel L, Besch V, Eichacker PQ.

Intensive Care Med. 2010 Jan;36(1):148-56. doi: 10.1007/s00134-009-1643-9. Epub 2009 Sep 15.

16.

Cellular and systemic effects of anthrax lethal toxin and edema toxin.

Moayeri M, Leppla SH.

Mol Aspects Med. 2009 Dec;30(6):439-55. doi: 10.1016/j.mam.2009.07.003. Epub 2009 Jul 26. Review.

17.

Raxibacumab for the treatment of inhalational anthrax.

Migone TS, Subramanian GM, Zhong J, Healey LM, Corey A, Devalaraja M, Lo L, Ullrich S, Zimmerman J, Chen A, Lewis M, Meister G, Gillum K, Sanford D, Mott J, Bolmer SD.

N Engl J Med. 2009 Jul 9;361(2):135-44. doi: 10.1056/NEJMoa0810603.

18.

Activation of plasminogen activator inhibitor implicates protease InhA in the acute-phase response to Bacillus anthracis infection.

Chung MC, Jorgensen SC, Popova TG, Tonry JH, Bailey CL, Popov SG.

J Med Microbiol. 2009 Jun;58(Pt 6):737-44. doi: 10.1099/jmm.0.007427-0.

PMID:
19429749
19.

Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats.

Li Y, Cui X, Su J, Haley M, Macarthur H, Sherer K, Moayeri M, Leppla SH, Fitz Y, Eichacker PQ.

Crit Care Med. 2009 Apr;37(4):1348-54. doi: 10.1097/CCM.0b013e31819cee38.

20.

Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008.

Anaraki S, Addiman S, Nixon G, Krahé D, Ghosh R, Brooks T, Lloyd G, Spencer R, Walsh A, McCloskey B, Lightfoot N.

Euro Surveill. 2008 Dec 18;13(51). pii: 19076.

Supplemental Content

Support Center